Group publishes audited FY 2024 financial statements and management report. Key financial figures in Swiss francs for transparency ...

Oxurion NV ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC over verkoop van aandelen. Bedrijf combineert therapeutische innovatie met klinisch onderzoekstechnologieën ...

Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC as it crosses under 10% shareholding threshold by selling voting securities. Company focused on therapeutic innov ...